Drug Shortage Report for XERESE
| Report ID | 3303 |
| Drug Identification Number | 02404044 |
| Brand name | XERESE |
| Common or Proper name | XERESE |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ACYCLOVIR HYDROCORTISONE |
| Strength(s) | 5% 1% |
| Dosage form(s) | CREAM |
| Route of administration | TOPICAL |
| Packaging size | 5G |
| ATC code | D06BB |
| ATC description | CHEMOTHERAPEUTICS FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-04-24 |
| Actual start date | |
| Estimated end date | 2017-05-22 |
| Actual end date | 2017-05-24 |
| Shortage status | Resolved |
| Updated date | 2017-05-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2017-05-25 | French | Compare |
| v6 | 2017-05-25 | English | Compare |
| v5 | 2017-04-25 | English | Compare |
| v4 | 2017-04-07 | French | Compare |
| v3 | 2017-04-07 | English | Compare |
| v2 | 2017-03-17 | French | Compare |
| v1 | 2017-03-17 | English | Compare |
Showing 1 to 7 of 7